Cargando…
miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
Ovarian cancer presents as an aggressive, advanced stage cancer with widespread metastases that depend primarily on multicellular spheroids in the peritoneal fluid. To identify new druggable pathways related to metastatic progression and spheroid formation, we integrated microRNA and mRNA sequencing...
Autores principales: | Pan, Yinghong, Robertson, Gordon, Pedersen, Lykke, Lim, Emilia, Hernandez-Herrera, Anadulce, Rowat, Amy C., Patil, Sagar L., Chan, Clara K., Wen, Yunfei, Zhang, Xinna, Basu-Roy, Upal, Mansukhani, Alka, Chu, Andy, Sipahimalani, Payal, Bowlby, Reanne, Brooks, Denise, Thiessen, Nina, Coarfa, Cristian, Ma, Yussanne, Moore, Richard A., Schein, Jacquie E., Mungall, Andrew J., Liu, Jinsong, Pecot, Chad V., Sood, Anil K., Jones, Steven J.M., Marra, Marco A., Gunaratne, Preethi H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041955/ https://www.ncbi.nlm.nih.gov/pubmed/27036018 http://dx.doi.org/10.18632/oncotarget.8412 |
Ejemplares similares
-
Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer
por: Pan, Yinghong, et al.
Publicado: (2017) -
MicroRNA-509-3p inhibits cellular migration, invasion, and proliferation, and sensitizes osteosarcoma to cisplatin
por: Patil, Sagar L., et al.
Publicado: (2019) -
PPARγ agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity
por: Basu-Roy, Upal, et al.
Publicado: (2016) -
Tumor microRNA profile and prognostic value for lymph node metastasis in oral squamous cell carcinoma patients
por: Liu, Kelly Yi Ping, et al.
Publicado: (2020) -
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53‐altered tumors
por: Gunaratne, Preethi H., et al.
Publicado: (2019)